Appendix 4E Variance Report
Filed with ASX · · 1 page · English
Summary by 6ix AI
It explains adjustments made following an independent valuation related to the acquisition of Reliis Pty Ltd. The report highlights changes in administration expenses, goodwill, intangibles, and reserves due to the finalization of acquisition accounting. These adjustments reflect a revised fair value assessment impacting the financial position of the company.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Patrys
- First Participants Dosed in RLS-2202 Phase 1A Clinical Trial
- PAB Establishes Clinical Advisory Committee
- Ethics Approval Secured for Phase 1A Clinical Trial
- Investor Presentation - TechKnow Invest Roadshow
- Appendix 4C - Quarterly - 30 June 2026
Later from Patrys
- Investor Webinar
- Investor Presentation
- RLS-2202 Phase 1a Trial Advances to Cohort 2
- Appendix 4C - Quarterly - 30 September 2026
Follow Patrys into a list and get an email when it puts out news.
Follow Patrys